Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study

Figure 1

Representative examples of immunohistochemical stainings of primary breast cancer tissues for respectively no expression and high expression of MIC-AB (A: intensity 0 (negative); B: intensity 2 (intermediate)), ULBP-1 (C: intensity 0 (negative); D: intensity 2 (intermediate)), ULBP-2 (E: intensity 0 (negative); F: intensity 3 (strong)), ULBP-3 (G: intensity 0 (negative); H: intensity 3 (strong)), ULBP-4 (I: intensity 0 (negative); J: intensity 1 (weak)), and ULBP-5 (K: intensity 0 (negative); L: intensity 3 (strong)) in breast cancer. Immunohistochemistry was performed according to standard protocols as described in Materials and Methods.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us